Barimbao, Servando B.

HRN: 06-29-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
CEFUROXIME 750MG (VIAL)
05/03/2022
05/09/2022
IV
1.5 Then 750mg
Q8
Indirect Inguinal Hernia, R
Waiting Final Action 
05/04/2022
CEFUROXIME 750MG (VIAL)
05/04/2022
05/10/2022
IV
750mg
Q8
Indirect Inguinal Hernia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: